Clinical Trials
23 trialsNCT03832985 2026-04-09
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
Phase EARLY_PHASE1 Completed
NCT04407611 2026-04-01
BWHS RoR
Boston University
Phase NA Completed
NCT05721326 2026-01-13
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03426878 2025-09-11
CHARM
Kaiser Permanente
Phase NA Completed
NCT06534424 2025-06-27
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT00673335 2024-07-01
LIBER
UNICANCER
Phase 3 Completed
NCT02087592 2024-04-16
LIBRE
Technical University of Munich
Phase NA Completed
NCT05306002 2024-03-05
Nutritional Intervention and DNA Damage of Patients With HBOC
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Phase NA Completed
NCT04544501 2022-05-02
Enhance the Use of Genetic Counseling and Testing in Latinas
Georgetown University
Phase NA Completed
NCT03511690 2022-04-25
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
Georgetown University
Phase NA Completed
NCT02956681 2021-10-04
Statewide Communication to Reach Diverse Low Income Women
University of California, San Francisco
Phase NA Completed
NCT00305695 2020-03-24
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
GOG Foundation
Phase 2 Completed
NCT03075540 2019-12-12
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Georgetown University
Phase NA Completed
NCT02451735 2019-11-08
Genetic Counseling for Breast Cancer Survivors (GC for BC)
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT00892736 2018-06-29
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
National Cancer Institute (NCI)
Phase 1 Completed
NCT00685256 2017-05-17
Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children
Georgetown University
Phase 3 Completed
NCT02562170 2015-09-29
Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study
Medical University of Vienna
Phase 4 Completed
NCT00535119 2015-05-22
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT01367639 2013-11-25
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
Sheba Medical Center
Phase 2 Completed
NCT00321633 2013-08-26
Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01333748 2012-07-13
EXSAL
Centre Francois Baclesse
Phase 2 Completed
NCT00609505 2012-02-22
Telemedicine vs. Face-to-Face Cancer Genetic Counseling
Duke University
Phase NA Completed
NCT00253539 2011-04-13
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
The Cleveland Clinic
Phase 2 Completed